Skip to content
stoqly

e.l.f. Beauty

ELF NYSE Personal Care Products Financials FY2016–FY2026

e.l.f. Beauty's revenue rose 24.6% to $1.6 billion in fiscal 2026. Its operating margin was 4.5%, down from 12.0% a year earlier. Free cash flow was $190 million, up 64.8%. It paid out $50 million in dividends and buybacks, 26% of free cash flow. The diluted share count rose 1.7%.

Last close Β· Oct 23, 2026

$114.24

0.7%
Revenue Total sales reported in the income statement.
$1.6B
24.6% vs prior year
Operating margin Operating income as a share of revenue.
4.5%
7.5 pts
Net income Profit after all expenses, interest and tax.
$26.3M
76.5%
Free cash flow Cash from operations minus capital spending.
$190M
64.8%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
3.8%
10.9 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$6.8B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
114.2x
On $1.00 EPS (TTM)

What e.l.f. Beauty does

No business description yet.

Legal name
e.l.f. Beauty, Inc.
Fiscal year ends
March 31, 2026
Latest annual report
β€”
Accession Β· CIK
0001600033-26-000020
0001600033

Revenue and margins

e.l.f. Beauty had $1.6B of revenue in fiscal 2026, up 24.6% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $190M in fiscal 2026, 11.6% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

e.l.f. Beauty returned $50.0M to shareholders in fiscal 2026, 26% of free cash flow. The diluted share count rose 1.7%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value e.l.f. Beauty yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β€” the answer depends entirely on what you put in.

Discounted cash flow

Value per share

β€”

Adds net cash of βˆ’$552M and divides by 59.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

β€”

Reference multiples: today 114.2x Β· peers 23.4x Β· sector 24.2x.

Balance sheet

Cash, debt and the ratios that show how comfortably e.l.f. Beauty can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY22FY23FY24FY25FY26
Cash and short-term investments $43.4M$121M$108M$149M$290M
Debt incl. finance leases $96.9M$66.5M$262M$257M$842M
Net debt / EBITDA 0.9xβˆ’0.6x0.9x0.5x3.6x
Debt / equity 0.3x0.2x0.4x0.3x0.7x
Interest coverage 16.9x19.2x13.3x10.1x2.0x
Current ratio 3.0x2.8x1.6x3.1x2.4x
Quick ratio 1.7x2.1x1.0x2.0x1.7x
Total assets $495M$596M$1.1B$1.2B$2.4B
Total liabilities $182M$185M$487M$487M$1.3B
Shareholders' equity $312M$411M$643M$761M$1.1B
Net debt (βˆ’ = net cash) $53.5Mβˆ’$54.3M$154M$108M$552M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$16.9M

6 insiders

Of sales under plans

98%

$16.6M

DateInsiderTradeSharesPriceValueFiling
Oct 15, 2026 Joshua Allen FranksSVP, Operations Sold plan 7,926 $110.15 $0.9M Form 4
Oct 12, 2026 Joshua Allen FranksSVP, Operations Sold plan 8,366 $110.01 $0.9M Form 4
Oct 1, 2026 Tarang AminChief Executive Officer, Director Sold plan 47,000 $103.31 $4.9M Form 4
Sep 8, 2026 Joshua Allen FranksSVP, Operations Sold plan 200 $110.00 $0.0M Form 4
Sep 8, 2026 Mandy J FieldsSee Remarks Sold plan 16,065 $104.52 $1.7M Form 4
Sep 1, 2026 Joshua Allen FranksSVP, Operations Sold plan 5,512 $110.00 $0.6M Form 4
Aug 19, 2026 Joshua Allen FranksSVP, Operations Sold plan 5,718 $100.00 $0.6M Form 4
Aug 18, 2026 Lauren Cooks LevitanDirector Sold 1,034 $93.15 $0.1M Form 4
Aug 4, 2026 Kory MarchisottoSee Remarks Sold plan 12,173 $88.02 $1.1M Form 4
Jul 1, 2026 Jennifer Catherine HartnettChief Commercial Officer Sold plan 25,357 $80.00 $2.0M Form 4
Jul 1, 2026 Tarang AminChief Executive Officer, Director Sold plan 50,164 $78.24 $3.9M Form 4
Jun 9, 2026 Kory MarchisottoSee Remarks Sold 4,352 $51.53 $0.2M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY24FY25FY26
Net income is positive βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“
Return on assets rose βœ“ βœ• βœ•
Cash from operations exceeds net income βœ• βœ“ βœ“
Debt fell relative to assets βœ• βœ“ βœ•
Current ratio rose βœ• βœ“ βœ•
Share count didn't rise βœ• βœ• βœ•
Gross margin rose βœ“ βœ“ βœ•
Revenue rose relative to assets βœ“ βœ• βœ“
F-score 5 / 96 / 94 / 9
Accruals ratio 6.6%βˆ’1.8%βˆ’10.2%
Altman Z'' 2.463.922.18

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
e.l.f. Beauty ELF $6.8B 24.6% 4.5% 11.6% 3.8% 114.2x 4
Coty COTY $2.8B βˆ’1.5% βˆ’1.4% 6.0% βˆ’1.0% β€” 3 Compare β†’
EstΓ©e Lauder Companies EL $39.6B 5.1% 5.2% 8.7% 4.9% β€” 6 Compare β†’
Kenvue KVUE $37.6B βˆ’2.1% 16.0% 11.4% 10.0% 22.5x 6 Compare β†’
Procter & Gamble PG $387.6B 3.3% 22.7% 17.4% 20.1% 24.3x 6 Compare β†’

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY20FY21FY22FY23FY24FY25FY26
Income statement
Revenue $230M $270M $267M $283M $318M $392M $579M $1.0B $1.3B $1.6B
Gross profit $132M $165M $163M $181M $206M $252M $390M $724M $936M $1.2B
Operating income $23.1M $33.3M $26.2M $29.9M $9.4M $29.8M $68.1M $150M $158M $73.6M
Interest expense $16.3M $8.8M $7.8M $6.3M $3.0M $1.8M $3.5M $11.3M $15.7M $37.4M
Pretax income $9.8M $22.5M $18.0M $24.1M $3.7M $25.4M $64.1M $141M $146M $40.5M
Income tax $4.5M βˆ’$11.0M $2.4M $6.2M βˆ’$2.5M $3.7M $2.5M $13.3M $33.4M $14.1M
Net income $5.3M $33.5M $15.5M $17.9M $6.2M $21.8M $61.5M $128M $112M $26.3M
Diluted EPS βˆ’$39.47 $0.68 $0.32 $0.35 $0.12 $0.41 $1.11 $2.21 $1.92 $0.44
Diluted shares 0.01B 0.05B 0.05B 0.05B 0.05B 0.05B 0.06B 0.06B 0.06B 0.06B
Cash flow
Cash from operations $2.1M $12.4M $55.6M $44.3M $29.5M $19.5M $102M $71.2M $134M $213M
Capital expenditure $9.2M $7.5M $8.9M $9.4M $6.5M $4.8M $1.7M $8.7M $18.5M $22.4M
Free cash flow βˆ’$7.1M $4.8M $46.7M $34.9M $23.0M $14.7M $100M $62.5M $115M $190M
Depreciation and amortization $13.2M $14.5M $17.9M $22.8M $25.2M $27.1M $17.6M $30.2M $44.1M $79.4M
Stock-based compensation $7.1M $13.5M $16.8M $15.5M $19.7M $19.6M $29.1M $40.6M $71.8M $86.9M
Acquisitions $0.0M $0.0M $0.0M $25.9M $0.0M $0.0M $0.0M $275M $0.0M $582M
Share buybacks $0.0M $0.0M $0.0M $7.9M $0.0M $0.0M $0.0M $0.0M $67.1M $50.0M
Dividends paid $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Dividends and buybacks $0.0M $0.0M $0.0M $7.9M $0.0M $0.0M $0.0M $0.0M $67.1M $50.0M
Balance sheet
Cash and short-term investments $15.3M $10.1M $51.2M $46.2M $57.8M $43.4M $121M $108M $149M $290M
Total debt $165M $156M $150M $139M $127M $96.9M $66.5M $262M $257M $842M
Finance lease liabilities $0.0M $0.0M $4.0M $3.0M $2.2M $1.4M $0.6M $0.1M $0.0M $0.0M
Current assets $125M $124M $142M $132M $170M $193M $303M $477M $541M $789M
Current liabilities $80.3M $51.4M $43.0M $51.1M $73.3M $65.0M $108M $299M $177M $336M
Inventory $69.4M $62.7M $46.3M $46.2M $56.8M $84.5M $81.3M $192M $187M $220M
Property and equipment, net $17.2M $18.0M $21.8M $17.2M $13.8M $10.6M $7.9M $14.0M $28.8M $41.5M
Total assets $415M $417M $436M $453M $487M $495M $596M $1.1B $1.2B $2.4B
Total liabilities $274M $223M $207M $211M $218M $182M $185M $487M $487M $1.3B
Shareholders' equity $141M $194M $229M $242M $270M $312M $411M $643M $761M $1.1B
Margins
Gross margin 57.6% 61.0% 60.9% 64.0% 64.8% 64.2% 67.4% 70.7% 71.2% 70.7%
Operating margin 10.1% 12.3% 9.8% 10.6% 3.0% 7.6% 11.8% 14.6% 12.0% 4.5%
EBITDA margin 15.8% 17.7% 16.5% 18.7% 10.9% 14.5% 14.8% 17.6% 15.4% 9.4%
Net margin 2.3% 12.4% 5.8% 6.3% 2.0% 5.6% 10.6% 12.5% 8.5% 1.6%
FCF margin βˆ’3.1% 1.8% 17.5% 12.3% 7.2% 3.8% 17.3% 6.1% 8.8% 11.6%
Returns
Return on capital 6.9% 10.6% 6.8% β€” 2.8% 7.2% 18.1% 23.5% 14.6% 3.8%
Return on capital employed 7.1% 9.5% 6.9% β€” 2.3% 7.1% 14.9% 22.7% 16.6% 4.7%
Return on equity 13.2% 20.0% 7.3% β€” 2.4% 7.5% 17.0% 24.2% 16.0% 2.8%
Return on assets 1.4% 8.1% 3.6% β€” 1.3% 4.4% 11.3% 14.8% 9.4% 1.5%
Growth
Revenue growth 19.9% 17.6% βˆ’0.9% β€” 12.5% 23.3% 47.6% 76.9% 28.3% 24.6%
Net income growth 21.9% 530.1% βˆ’53.6% β€” βˆ’65.2% 249.3% 182.6% 107.5% βˆ’12.2% βˆ’76.5%
EPS growth β€” β€” βˆ’52.9% β€” βˆ’65.7% 241.7% 170.7% 99.1% βˆ’13.1% βˆ’77.1%
FCF growth βˆ’149.4% β€” 866.3% β€” βˆ’34.1% βˆ’36.1% 581.6% βˆ’37.6% 84.5% 64.8%
Share count change βˆ’58.7% 291.7% βˆ’0.2% β€” 2.3% 3.2% 3.1% 4.4% 1.0% 1.7%
Financial health
Net debt / EBITDA 4.1x 3.1x 2.3x 1.8x 2.0x 0.9x βˆ’0.6x 0.9x 0.5x 3.6x
Debt / equity 1.2x 0.8x 0.7x 0.6x 0.5x 0.3x 0.2x 0.4x 0.3x 0.7x
Interest coverage 1.4x 3.8x 3.4x 4.8x 3.1x 16.9x 19.2x 13.3x 10.1x 2.0x
Current ratio 1.6x 2.4x 3.3x 2.6x 2.3x 3.0x 2.8x 1.6x 3.1x 2.4x
Quick ratio 0.7x 1.2x 2.2x 1.7x 1.6x 1.7x 2.1x 1.0x 2.0x 1.7x
Capital allocation
Capex / revenue 4.0% 2.8% 3.3% 3.3% 2.0% 1.2% 0.3% 0.9% 1.4% 1.4%
Stock comp / revenue 3.1% 5.0% 6.3% 5.5% 6.2% 5.0% 5.0% 4.0% 5.5% 5.3%
Payouts / FCF β€” 0.0% 0.0% 22.7% 0.0% 0.0% 0.0% 0.0% 58.2% 26.3%
Quality scores
Piotroski F-score β€” 7.0 6.0 β€” β€” 6.0 7.0 5.0 6.0 4.0
Altman Z'' βˆ’2.8 βˆ’1.5 βˆ’0.8 βˆ’0.9 βˆ’0.7 0.7 3.0 2.5 3.9 2.2
Accruals ratio 0.8% 5.1% βˆ’9.4% β€” βˆ’4.9% 0.5% βˆ’7.4% 6.6% βˆ’1.8% βˆ’10.2%

Source: SEC EDGAR XBRL filings (CIK 0001600033). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open